Show simple item record

Razvoj i validacija RP-HPLC metode za praćenje stabilnosti u cilju određivanja sadržaja aripiprazola i njegovih degradacionih proizvoda

dc.creatorMijatović, Vesna
dc.creatorZečević, Mira
dc.creatorZirojević, Jelena
dc.date.accessioned2023-08-25T09:22:53Z
dc.date.available2023-08-25T09:22:53Z
dc.date.issued2023
dc.identifier.issn0004-1963
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/4977
dc.description.abstractThe goal of this study was the optimization of chromatographic conditions and validation of the isocratic RP-HPLC method for monitoring the stability of aripiprazole, identification and quantitative analysis of aripiprazole and its degradation products in tablets. In addition, robustness was tested by applying the methodology of experimental design. The forced degradation study of aripiprazole was conducted in accordance with the ICH guidelines. The stability of the active pharmaceutical substance was tested under the conditions of hydrolysis in acidic, neutral and basic environments, thermal degradation, oxidation and photolysis. The active pharmaceutical ingredient was degraded under oxidation conditions, and the identity of the resulting degradation product, N-oxide, was confirmed. Under the other conditions tested, the active pharmaceutical substance was found to be stable. The developed method RP-HPLC allowed the separation of degradation products and aripiprazole and was defined as a stability-indicating method. The proposed method was validated for qualitative and quantitative analysis of aripiprazole and its degradation products. Accordingly, selectivity, linearity, precision, accuracy, limit of detection, limit of quantification, and robustness of the method were tested. The Box-Behnken experimental design was used in robustness testing.sr
dc.description.abstractCilj rada bio je optimizacija hromatografskih uslova i validacija izokratske HPLC metode za praćenje stabilnosti aripiprazola, identifikacija i kvantitativna analiza aripiprazola i njegovih degradacionih proizvoda u tabletama, kao i ispitivanje robusnosti predložene analitičke metode primenom eksperimentalnog dizajna. Studija forsirane degradacije aktivne farmaceutske supstance aripiprazola sprovedena je u skladu sa ICH smernicama. Ispitivana je stabilnost aktivne supstance u uslovima hidrolize u kiseloj, neutralnoj i baznoj sredini, termalne degradacije, oksidacije i fotolize. Aktivna supstanca je pokazala degradaciju u uslovima oksidacije, pri čemu je potvrđen identitet nastalog proizvoda, N-oksida, Pri ostalim ispitivanim uslovima, aktivna farmaceutska supstanca je pokazala stabilnost. Kako je predložena RP-HPLC metoda omogućila efikasno razdvajanje degradacionih proizvoda i aripiprazola, definisana je kao metoda za praćenje stabilnosti farmaceutskog proizvoda. Sprovedena je validacija predložene metode za istovremenu identifikaciju i kvantifikaciju aripiprazola i njegovih degradacionih proizvoda. Tom prilikom su ispitani selektivnost, linearnost, preciznost, tačnost, limit detekcije i limit kvantifikacije, a primenom Box- Behnkenovog eksperimentalnog dizajna ispitana je i robusnost metode.sr
dc.language.isosrsr
dc.language.isoensr
dc.publisherSavez farmaceutskih udruženja Srbije (SFUS)sr
dc.rightsopenAccesssr
dc.rights.urihttps://creativecommons.org/licenses/by-sa/4.0/
dc.sourceArhiv za farmacijusr
dc.subjectaripiprazolesr
dc.subjectliquid chromatographysr
dc.subjectBox-Behnken experimental designsr
dc.subjectforced degradation studysr
dc.subjectdegradation productssr
dc.subjectaripiprazolsr
dc.subjecttečna hromatografijasr
dc.subjectBox-Behnken eksperimentalni dizajnsr
dc.subjectforsirana degradacijasr
dc.subjectdegradacioni proizvodisr
dc.titleDevelopment and validation of a stability- indicating RP-HPLC method for determination of aripiprazole and its degradation productssr
dc.titleRazvoj i validacija RP-HPLC metode za praćenje stabilnosti u cilju određivanja sadržaja aripiprazola i njegovih degradacionih proizvodasr
dc.typearticlesr
dc.rights.licenseBY-SAsr
dc.citation.volume73
dc.citation.issue3
dc.citation.spage216
dc.citation.epage235
dc.citation.rankM51~
dc.identifier.doi10.5937/arhfarm73-44512
dc.identifier.fulltexthttp://farfar.pharmacy.bg.ac.rs/bitstream/id/13687/Development_and_validation_pub_2023.pdf
dc.type.versionpublishedVersionsr


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record